Literature DB >> 8674203

Reference calibrators for IgG antibodies to beta2-glycoprotein I: preparation, properties and availability to investigators.

E N Erickson1, S S Najmey, L B Keil, H S El-Kadi, V A DeBari.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8674203

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  Prevalence of antibodies against oxidised LDL in a cohort of 163 patients with positive anti-phospholipid antibodies and recent thrombosis.

Authors:  Henning Locht; Allan Wiik
Journal:  Rheumatol Int       Date:  2005-09-28       Impact factor: 2.631

2.  IgG and IgM isotypes of anti-cardiolipin and anti-beta2-glycoprotein i antibodies reflect different forms of recent thrombo-embolic events.

Authors:  Henning Locht; Allan Wiik
Journal:  Clin Rheumatol       Date:  2005-09-22       Impact factor: 2.980

3.  Antiphosphatidylserine antibodies in patients with autoimmune diseases and HIV-infected patients: effects of Tween 20 and relationship with antibodies to beta2-glycoprotein I.

Authors:  C González; A Lestón; B García-Berrocal; A Sánchez-Rodriguez; J A Martín-Oterino; I Alberca; M Cordero; R Jorge; J A Navajo; J M González-Buitrago
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

4.  Isotype distribution and clinical relevance of anti-beta2-glycoprotein I (beta2-GPI) antibodies: importance of IgA isotype.

Authors:  G Lakos; E Kiss; N Regëczy; P Tarján; P Soltész; M Zeher; E Bodolay; S Szakony; S Sipka; G Szegedi
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

5.  Standardized measurement of major immunoglobulin class (IgG, IgA, and IgM) antibodies to beta2glycoprotein I in patients with antiphospholipid syndrome.

Authors:  S Lewis; L B Keil; W L Binder; V A DeBari
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

6.  High prevalence of autoantibodies among Danish centenarians.

Authors:  K Andersen-Ranberg; M HØier-Madsen; A Wiik; B Jeune; L Hegedus
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.